Heide Ford, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz

Heide Ford, University of Colorado Anschutz Medical Campus

Caption

Heide Ford, PhD, and University of Colorado Cancer Center colleagues show that Eya3 may regulate immune response to triple-negative breast cancer, potentially improving immunotherapies against the disease.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.